Proteinopathy, oxidative stress and mitochondrial dysfunction: cross talk in Alzheimer’s disease and Parkinson’s disease

References

• DavieCAA review of Parkinson’s diseaseBr Med Bull2008861 109 12718398010
   PubMed Web of Science ®Google Scholar
• ChakrabartiSKhemkaVKBanerjeeAChatterjeeGGangulyABiswasAMetabolic risk factors of sporadic Alzheimer’s disease: implications in the pathology, pathogenesis and treatmentAging Dis201564 282 29926236550
   PubMed Web of Science ®Google Scholar
• NussbaumRLEllisCEAlzheimer’s disease and Parkinson’s diseaseN Engl J Med200334814 1356 136412672864
   PubMed Web of Science ®Google Scholar
• XieAGaoJXuLMengDShared mechanisms of neurodegeneration in Alzheimer’s disease and Parkinson’s diseaseBiomed Res Int20142014 64874024900975
   PubMed Web of Science ®Google Scholar
• PerierCVilaMMitochondrial biology and Parkinson’s diseaseCold Spring Harb Perspect Med201122 a009332
   Web of Science ®Google Scholar
• BondaDJSmithMAPerryGLeeHGWangXZhuXThe mitochondrial dynamics of Alzheimer’s disease and Parkinson’s disease offer important opportunities for therapeutic interventionCurr Pharm Des20111731 3374 338021902671
   PubMed Web of Science ®Google Scholar
• SubramaniamSRChesseletMFMitochondrial dysfunction and oxidative stress in Parkinson’s diseaseProg Neurobiol2013 106 107 17 3224012715
   PubMed Web of Science ®Google Scholar
• XieWWanOWChungKKNew insights into the role of mitochondrial dysfunction and protein aggregation in Parkinson’s diseaseBiochim Biophys Acta2010180211 935 94120674742
   PubMed Web of Science ®Google Scholar
• ButterfieldDALauderbackCMLipid peroxidation and protein oxidation in Alzheimer’s disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stressFree Radic Biol Med20023211 1050 106012031889
   PubMed Web of Science ®Google Scholar
• ReddyPHBealMFAmyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer’s diseaseTrends Mol Med2008142 45 5318218341
   PubMed Web of Science ®Google Scholar
• CooksonMRα-Synuclein and neuronal cell deathMol Neurodegener20094 919193223
   PubMed Web of Science ®Google Scholar
• SelkoeDJHardyJThe amyloid hypothesis of Alzheimer’s disease at 25 yearsEMBO Mol Med201686 595 60827025652
   PubMed Web of Science ®Google Scholar
• FriedrichRPTepperKRonickeRMechanism of amyloid plaque formation suggests an intracellular basis of a pathogenicityProc Natl Acad Sci U S A20101075 1942 194720133839
   PubMed Web of Science ®Google Scholar
• UverskyVNEliezerDBiophysics of Parkinson’s Disease: structure and aggregation of α-synucleinCurr Protein Peptide Sci200910 483 49919538146
   PubMed Web of Science ®Google Scholar
• KovacsGGBudkaHCurrent concepts of neuropathological diagnostics in practice: neurodegenerative diseasesClin Neuropathol2010295 271 28820860890
   PubMed Web of Science ®Google Scholar
• O’brienRJWongPCAmyloid precursor protein processing and Alzheimer’s diseaseAnn Rev Neurosci201134 185 20421456963
   PubMed Web of Science ®Google Scholar
• CahillCMLahiriDKHuangXRogersJTAmyloid precursor protein and alpha synuclein translation, implications for iron and inflammation in neurodegenerative diseasesBiochim Biophys Acta200917907 615 62819166904
   PubMed Web of Science ®Google Scholar
• JowaedASchmittIKautOWüllnerUMethylation regulates alpha-synuclein expression and is decreased in Parkinson’s disease patients’ brainsJ Neurosci20103018 6355 635920445061
   PubMed Web of Science ®Google Scholar
• TakaloMSalminenASoininenHHiltunenMHaapasaloAProtein aggregation and degradation mechanisms in neurodegenerative diseasesAm J Neurodegener Dis201321 1 1423516262
   PubMedGoogle Scholar
• CiechanoverAKwonYTDegradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategiesExp Mol Med201547 e14725766616
   PubMed Web of Science ®Google Scholar
• MorimotoRIProteotoxic stress and inducible chaperone networks in neurodegenerative disease and agingGenes Dev20082211 1427 143818519635
   PubMed Web of Science ®Google Scholar
• NiforouKCheimonidouCTrougakosIPMolecular chaperones and proteostasis regulation during redox imbalanceRedox Biol20142 323 33224563850
   PubMed Web of Science ®Google Scholar
• SenCKPackerLAntioxidant and redox regulation of gene transcriptionFASEB J1996107 709 7208635688
   PubMed Web of Science ®Google Scholar
• AikenCTKaakeRMWangXHuangLOxidative stress-mediated regulation of proteasome complexesMol Cell Proteomics2011105 R110.006924
   Web of Science ®Google Scholar
• PajaresMJiménez-morenoNDiasIHRedox control of protein degradationRedox Biol20156 409 42026381917
   PubMed Web of Science ®Google Scholar
• XiangWMengesSSchlachetzkiJPosttranslational modification and mutation of histidine 50 trigger alpha synuclein aggregation and toxicityMol Neurodegener201510 825886189
   PubMed Web of Science ®Google Scholar
• SneadDEliezerDAlpha-synuclein function and dysfunction on cellular membranesExp Neurobiol2014234 292 31325548530
   PubMedGoogle Scholar
• BanerjeeKSinhaMPham CleLAlpha-synuclein induced membrane depolarization and loss of phosphorylation capacity of isolated rat brain mitochondria: implications in Parkinson’s diseaseFEBS Lett20105848 1571 157620226185
   PubMed Web of Science ®Google Scholar
• WangXSuBLeeHImpaired balance of mitochondrial fission and fusion in Alzheimer’s diseaseJ Neurosci20092928 9090 910319605646
   PubMed Web of Science ®Google Scholar
• DeviLPrabhuBMGalatiDFAvadhaniNGAnandatheerthavaradaHKAccumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer’s disease brain is associated with mitochondrial dysfunctionJ Neurosci20062635 9057 906816943564
   PubMed Web of Science ®Google Scholar
• ProtterDLangCCooperAAα-Synuclein and mitochondrial dysfunction: a pathogenic partnership in Parkinson’s diseaseParkinson’s Dis20122012
   Web of Science ®Google Scholar
• DongSDuanYHuYZhaoZAdvances in the pathogenesis of Alzheimer’s disease: a re-evaluation of amyloid cascade hypothesisTransl Neurodegener201211 1823210692
   PubMedGoogle Scholar
• ArmstrongRAThe pathogenesis of Alzheimer’s disease: a reevaluation of the Amyloid cascade HypothesisInt J Alzheimers Dis20112011 1 6
   Google Scholar
• JiangSLiYZhangXBuGXuHZhangYTrafficking regulation of proteins in Alzheimer’s diseaseMol Neurodegener20149 624410826
   PubMed Web of Science ®Google Scholar
• Mondragón-rodríguezSPerryGZhuXMoreiraPIAcevedo-aquinoMCWilliamsSPhosphorylation of tau protein as the link between oxidative stress, mitochondrial dysfunction, and connectivity failure: implications for Alzheimer’s diseaseOxid Med Cell Longev20132013 94060323936615
   PubMed Web of Science ®Google Scholar
• AlonsoACGrundke-IqbalIIqbalKAlzheimer’s disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubulesNat Med199627 783 7878673924
   PubMed Web of Science ®Google Scholar
• ButterfieldDASwomleyAMSultanaSAmyloid β-peptide (1–42)-induced oxidative stress in Alzheimer disease: importance in disease pathogenesis and progressionAntioxid Redox Signal201319 823 83523249141
   PubMed Web of Science ®Google Scholar
• ButterfieldDADi DomenicoFSwomleyAMHeadEPerluigiMRedox proteomics analysis to decipher the neurobiology of Alzheimer-like neurodegeneration: overlaps in down’s syndrome and Alzheimer’s disease brainBiochem J20144632 177 18925242166
   PubMed Web of Science ®Google Scholar
• TheunsJVan BroeckhovenCTranscriptional regulation of Alzheimer’s disease genes: implications for susceptibilityHum Mol Genet2000916 2383 239411005793
   PubMed Web of Science ®Google Scholar
• HoffmanPWChernakJMDNA binding and regulatory effects of transcription factors SP1 and USF at the rat amyloid precursor protein gene promoterNucleic Acids Res19952312 2229 22357610052
   PubMed Web of Science ®Google Scholar
• PiconePNuzzoDCaruanaLMetformin increases APP expression and processing via oxidative stress, mitochondrial dysfunction and NF-kB activation: use of insulin to attenuate metformin’s effectBiochim Biophys Acta201518535 1046 105925667085
   PubMed Web of Science ®Google Scholar
• KoSYLinYPLinYSChangSSAdvanced glycation end products enhance amyloid precursor protein expression by inducing reactive oxygen speciesFree Radic Biol Med2010493 474 48020471471
   PubMed Web of Science ®Google Scholar
• RogersJTRandallJDCahillCMAn iron-responsive element type II in the 5′-untranslated region of the Alzheimer’s amyloid precursor protein transcriptJ Biol Chem200227747 45518 4552812198135
   PubMed Web of Science ®Google Scholar
• HuangXMoirRDTanziREBushAIRogersJTRedox-active metals, oxidative stress, and Alzheimer’s disease pathologyAnn N Y Acad Sci20041012 153 16315105262
   PubMed Web of Science ®Google Scholar
• ChenXFZhangYWXuHBuGTranscriptional regulation and its misregulation in Alzheimer’s diseaseMol Brain20136 4424144318
   PubMed Web of Science ®Google Scholar
• ChamiLCheclerFBACE1 is at the crossroad of a toxic vicious cycle involving cellular stress and β-amyloid production in Alzheimer’s diseaseMol Neurodegener20127 5223039869
   PubMed Web of Science ®Google Scholar
• GuglielmottoMAragnoMAutelliRThe up-regulation of BACE1 mediated by hypoxia and ischemic injury: role of oxidative stress and HIF1alphaJ Neurochem20091084 1045 105619196431
   PubMed Web of Science ®Google Scholar
• KaurUBanerjeePBirASinhaMBiswasAChakrabartiSReactive oxygen species, redox signaling and neuroinflammation in Alzheimer’s disease: the NF-kB connectionCurr Top Med Chem2015155 446 45725620241
   PubMed Web of Science ®Google Scholar
• TongYZhouWFungVOxidative stress potentiates BACE1 gene expression and Abeta generationJ Neural Transm20041123 455 46915614428
   PubMed Web of Science ®Google Scholar
• TamagnoEBardiniPObbiliAOxidative stress increases expression and activity of BACE in NT2 neuronsNeurobiol Dis2002103 279 28812270690
   PubMed Web of Science ®Google Scholar
• TamagnoEParolaMBardiniPBeta-site APP cleaving enzyme up-regulation induced by 4-hydroxynonenal is mediated by stress-activated protein kinases pathwaysJ Neurochem2005923 628 63615659232
   PubMed Web of Science ®Google Scholar
• TamagnoEGuglielmottoMAragnoMOxidative stress activates a positive feedback between the γ- and β-secretase cleavages of the β-amyloid precursor proteinJ Neurochem20081043 683 69518005001
   PubMed Web of Science ®Google Scholar
• Mouton-ligerFPaquetCDumurgierJOxidative stress increases BACE1 protein levels through activation of the PKR-eIF2α pathwayBiochem Biophys Acta201218226 885 89622306812
   PubMed Web of Science ®Google Scholar
• MisonouHMorishima-kawashimaMIharaYOxidative stress induces intracellular accumulation of amyloid beta-protein (Abeta) in human neuroblastoma cellsBiochemistry20003923 6951 695910841777
   PubMed Web of Science ®Google Scholar
• DeaneRBellRDSagareAZlokovicBVClearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer’s diseaseCNS Neurol Disord Drug Targets200981 16 3019275634
   PubMed Web of Science ®Google Scholar
• BatesKAVerdileGLiQ-XClearance mechanisms of Alzheimer’s amyloid-β peptide: implications for therapeutic design and diagnostic testsMol Psychiatr2008145 469 486
   Web of Science ®Google Scholar
• RamanathanANelsonARSagareAPZlokovicBVImpaired vascular-mediated clearance of brain amyloid beta in Alzheimer’s disease: the role, regulation and restoration of LRP1Front Aging Neurosci20157 13626236233
   PubMed Web of Science ®Google Scholar
• KadowakiHNishitohHUranoFAmyloid β induces neuronal cell death through ROS-mediated ASK1 activationCell Death Differ2005121 19 2415592360
   PubMed Web of Science ®Google Scholar
• BehlCHydrogen peroxide mediates amyloid β protein toxicityCell1994776 817 8278004671
   PubMed Web of Science ®Google Scholar
• ChakrabartiSSinhaMThakurtaIGBanerjeePChattopadhyayMOxidative stress and amyloid beta toxicity in Alzheimer’s disease: intervention in a complex relationship by antioxidantsCurr Med Chem20132037 4648 466423834172
   PubMed Web of Science ®Google Scholar
• SmithDGCappaiRBarnhamKJThe redox chemistry of the Alzheimer’s disease amyloid β peptideBiochim Biophys Acta200717688 1976 199017433250
   PubMed Web of Science ®Google Scholar
• SinhaMBhowmickPBanerjeeAChakrabartiSAntioxidant role of amyloid β protein in cell-free and biological systems: implication for the pathogenesis of Alzheimer diseaseFree Radic Biol Med201356 184 19223041348
   PubMed Web of Science ®Google Scholar
• ShelatPBChalimoniukMWangJHAmyloid beta peptide and NMDA induce ROS from NADPH oxidase and AA release from cytosolic phospholipase A2 in cortical neuronsJ Neurochem20081061 45 5518346200
   PubMed Web of Science ®Google Scholar
• HuHLiMMitochondria-targeted antioxidant mitotempo protects mitochondrial function against amyloid beta toxicity in primary cultured mouse neuronsBiochem Biophys Res Commun20164781 174 18027444386
   PubMed Web of Science ®Google Scholar
• QinLLiuYCooperCLiuBWilsonBHongJ-SMicroglia enhance β-amyloid peptide-induced toxicity in cortical and mesencephalic neurons by producing reactive oxygen speciesJ Neurochem2002834 973 98312421370
   PubMed Web of Science ®Google Scholar
• QinBCartierLDubois-dauphinMLiBSerranderLKrauseKHA key role for the microglial NADPH oxidase in APP-dependent killing of neuronsNeurobiol Aging20062711 1577 158716260066
   PubMed Web of Science ®Google Scholar
• DoensDFernándezPLMicroglia receptors and their implications in the response to amyloid β for Alzheimer’s disease pathogenesisJ Neuroinflammation201411 4824625061
   PubMed Web of Science ®Google Scholar
• CoraciISHusemannJBermanJWCD36, a class B scavenger receptor, is expressed on microglia in Alzheimer’s disease brains and can mediate production of reactive oxygen species in response to beta-amyloid fibrilsAm J Pathol20021601 101 11211786404
   PubMed Web of Science ®Google Scholar
• ZhangDHuXQianLMicroglial MAC1 receptor and PI3K are essential in mediating β-amyloid peptide-induced microglial activation and subsequent neurotoxicityJ Neuroinflammation201181 321232086
   PubMed Web of Science ®Google Scholar
• Mondragón-rodríguezSPerryGLuna-muñozJAcevedo-aquinoMCWilliamsSPhosphorylation of tau protein at sites Ser (396-404) is one of the earliest events in Alzheimer’s disease and Down syndromeNeuropathol Appl Neurobiol2014402 121 13524033439
   PubMed Web of Science ®Google Scholar
• Alavi NainiSMSoussi-yanicostasNTau hyperphosphorylation and oxidative stress, a critical vicious circle in neurodegenerative tauopathies?Oxid Med Cell Longev20152015 15197926576216
   PubMed Web of Science ®Google Scholar
• SuBWangXLeeHGChronic oxidative stress causes increased tau phosphorylation in M17 neuroblastoma cellsNeurosci Lett20104683 267 27119914335
   PubMed Web of Science ®Google Scholar
• GiraldoELloretAFuchsbergerTViñaJAβ and tau toxicities in Alzheimer’s are linked via oxidative stress-induced p38 activation: protective role of vitamin ERedox Biol20142 873 87725061569
   PubMed Web of Science ®Google Scholar
• LovellMAXiongSXieCDaviesPMarkesberyWRInduction of hyperphosphorylated tau in primary rat cortical neuron cultures mediated by oxidative stress and glycogen synthase kinase-3J Alzheimers Dis200466 659 67115665406
   PubMed Web of Science ®Google Scholar
• EgañaJTZambranoCNuñezMTGonzalez-billaultCMaccioniRBIron-induced oxidative stress modify tau phosphorylation patterns in hippocampal cell culturesBiometals2003161 215 22312572681
   PubMed Web of Science ®Google Scholar
• ZambranoCAEgañaJTNúñezMTMaccioniRBGonzález-billaultCOxidative stress promotes tau dephosphorylation in neuronal cells: the roles of cdk5 and PP1Free Radic Biol Med20043611 1393 140215135175
   PubMed Web of Science ®Google Scholar
• MoreiraPICarvalhoCZhuXSmithMAPerryGMitochondrial dysfunction is a trigger of Alzheimer’s disease pathophysiologyBiochim Biophys Acta201018021 2 1019853658
   PubMed Web of Science ®Google Scholar
• OnyangoIGDennisJKhanSMMitochondrial dysfunction in Alzheimer’s disease and the rationale for bioenergetics based therapiesAging Dis201672 201 21427114851
   PubMed Web of Science ®Google Scholar
• ChenJXYanSDAmyloid-beta-induced mitochondrial dysfunctionJ Alzheimers Dis2007122 177 18417917162
   PubMed Web of Science ®Google Scholar
• MossmannDVögtleFTaskinAAAmyloid-β peptide induces mitochondrial dysfunction by inhibition of preprotein maturationCell Metab2014204 662 66925176146
   PubMed Web of Science ®Google Scholar
• SpuchCOrtolanoSNavarroCNew insights in the amyloid-beta interaction with mitochondriaJ Aging Res20122012 32496822523685
   PubMedGoogle Scholar
• SinhaMBeheraPBhowmickPBanerjeeKBasuSChakrabartiSAging promotes amyloid-β peptide induced mitochondrial dysfunctions in rat brain: a molecular link between aging and Alzheimer’s diseaseJ Alzheimers Dis2011274 753 76521876248
   PubMed Web of Science ®Google Scholar
• ArispeNDiazJCSimakovaOAbeta ion channels. Prospects for treating Alzheimer’s disease with Abeta channel blockersBiochim Biophys Acta200717688 1952 196517490607
   PubMed Web of Science ®Google Scholar
• LalRLinHQuistAPAmyloid beta ion channel: 3D structure and relevance to amyloid channel paradigmBiochim Biophys Acta200717688 1966 197517553456
   PubMed Web of Science ®Google Scholar
• ZhuDLaiYShelatPBHuCSunGYLeeJCPhospholipases A2 mediate amyloid-beta peptide-induced mitochondrial dysfunctionJ Neurosci20062643 11111 1111917065451
   PubMed Web of Science ®Google Scholar
• AbramovAYCanevariLDuchenMRBeta-amyloid peptides induce mitochondrial dysfunction and oxidative stress in astrocytes and death of neurons through activation of NADPH oxidaseJ Neurosci2004242 565 57514724257
   PubMed Web of Science ®Google Scholar
• PringsheimTJetteNFrolkisASteevesTDLThe prevalence of Parkinson’s disease: a systematic review and meta-analysisMov Disord20142913 1583 159024976103
   PubMed Web of Science ®Google Scholar
• KleinCWestenbergerAGenetics of Parkinson’s diseaseCold Spring Harb Perspect Med201221 a00888822315721
   PubMed Web of Science ®Google Scholar
• BraakHGhebremedhinERübUBratzkeHDel TrediciKStages in the development of Parkinson’s disease-related pathologyCell Tissue Res20043181 121 13415338272
   PubMed Web of Science ®Google Scholar
• StefanisLSynuclein in Parkinson’s diseaseCold Spring Harb Perspect Med20112 a009399
   Web of Science ®Google Scholar
• SpillantiniMGCrowtherRAJakesRCairnsNJLantosPLGoedertMFilamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson’s disease and dementia with Lewy bodiesNeurosci Lett19982513 205 2089726379
   PubMed Web of Science ®Google Scholar
• DikiyIEliezerDFolding and misfolding of alpha-synuclein on membranesBiochim Biophys Acta201218184 1013 101821945884
   PubMed Web of Science ®Google Scholar
• LashuelHAOverkCROueslatiAMasliahEThe many faces of α-synuclein: from structure and toxicity to therapeutic targetNat Rev Neurosci2013141 38 4823254192
   PubMed Web of Science ®Google Scholar
• RoostaeeABeaudoinSStaskeviciusARoucouXAggregation and neurotoxicity of recombinant α-synuclein aggregates initiated by dimerizationMol Neurodegener20138 523339399
   PubMed Web of Science ®Google Scholar
• MatsumotoLTakumaHTamaokaACpG demethylation enhances alpha-synuclein expression and affects the pathogenesis of Parkinson’s diseasePLoS One2010511 e1552221124796
   PubMed Web of Science ®Google Scholar
• FebbraroFGiorgiMCaldarolaSLoreniFRomero-ramosMα-Synuclein expression is modulated at the translational level by ironNeuroreport2012239 576 58022581044
   PubMed Web of Science ®Google Scholar
• DehayBMartinez-vicenteMCaldwellGALysosomal impairment in Parkinson’s diseaseMov Disord2013286 725 73223580333
   PubMed Web of Science ®Google Scholar
• CookCPetrucelliLA critical evaluation of the ubiquitin-proteasome system in Parkinson’s diseaseBiochim Biophys Acta200917927 664 67519419700
   PubMed Web of Science ®Google Scholar
• McnaughtKSBelizaireRIsacsonOJennerPOlanowCWAltered proteasomal function in sporadic Parkinson’s diseaseExp Neurol20031791 38 4612504866
   PubMed Web of Science ®Google Scholar
• MyungJKimKBCrewsCMThe ubiquitin-proteasome pathway and proteasome inhibitorsMed Res Rev2001214 245 27311410931
   PubMed Web of Science ®Google Scholar
• McNaughtKSOlanowCWHalliwellBIsacsonOJennerPFailure of the ubiquitin–proteasome system in Parkinson’s diseaseNat Rev Neurosci200128 589 59411484002
   PubMed Web of Science ®Google Scholar
• McNaughtKSPerlDPBrownellALOlanowCWSystemic exposure to proteasome inhibitors causes a progressive model of Parkinson’s diseaseAnn Neurol2004561 149 16215236415
   PubMed Web of Science ®Google Scholar
• EriksenJLWszolekZPetrucelliLMolecular pathogenesis of Parkinson diseaseArch Neurol2005623 353 35715767499
   PubMedGoogle Scholar
• TanakaYEngelenderSIgarashiSInducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosisHum Mol Genet2001109 919 92611309365
   PubMed Web of Science ®Google Scholar
• Perez-AlvarezSSolesioMEManzanaresJJordánJGalindoMFLactacystin requires reactive oxygen species and BAX redistribution to induce mitochondria mediated cell deathBr J Pharmacol20091584 1121 113019785649
   PubMed Web of Science ®Google Scholar
• ZhouZDLimTMDopamine (DA) induced irreversible proteasome inhibition via DA derived quinonesFree Radic Res2009434 417 43019291591
   PubMed Web of Science ®Google Scholar
• SnyderHMensahKTheislerCLeeJMatouschekAWolozinBAggregated and monomeric alpha-synuclein bind to the S6′ proteasomal protein and inhibit proteasomal functionJ Biol Chem200327814 11753 1175912551928
   PubMed Web of Science ®Google Scholar
• Simón-sánchezJSchulteCBrasJMGenome-wide association study reveals genetic risk underlying Parkinson’s diseaseNat Genet20094112 1308 131219915575
   PubMed Web of Science ®Google Scholar
• Lo BiancoCRidetJLSchneiderBLDeglonNAebischerPAlpha-synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson’s diseaseProc Natl Acad Sci U S A20029916 10813 1081812122208
   PubMed Web of Science ®Google Scholar
• Oliveras-salváMVan der PerrenACasadeiNrAAV2/7 vector-mediated overexpression of alpha-synuclein in mouse substantia nigra induces protein aggregation and progressive dose-dependent neurodegenerationMol Neurodegener20138 4424267638
   PubMed Web of Science ®Google Scholar
• PaumierKLLukKCManfredssonFPIntrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degenerationNeurobiol Dis201582 185 19926093169
   PubMed Web of Science ®Google Scholar
• RecasensADehayBBovéJLewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeysAnn Neurol2014753 351 36224243558
   PubMed Web of Science ®Google Scholar
• BisagliaMGreggioEMaricDMillerDWCooksonMRBubaccoLAlpha-synuclein overexpression increases dopamine toxicity in BE2-M17 cellsBMC Neurosci201011 4120334701
   PubMed Web of Science ®Google Scholar
• MullinSSchapiraAA-synuclein and mitochondrial dysfunction in Parkinson’s diseaseMol Neurobiol2013472 587 59723361255
   PubMed Web of Science ®Google Scholar
• SchapiraAHVCooperJMDexterDClarkJBJennerPMarsdenCDMitochondrial complex I deficiency in Parkinson’s diseaseJ Neurochem1990543 823 8272154550
   PubMed Web of Science ®Google Scholar
• BlakeCISpitzELeeheyMHofferBJBoysonSJPlatelet mitochondrial respiratory chain function in Parkinson’s diseaseMov Disord1997121 3 88990047
   PubMed Web of Science ®Google Scholar
• BlinODesnuelleCRascolOMitochondrial respiratory failure in skeletal muscle from patients with Parkinson’s disease and multiple system atrophyJ Neurol Sci19941251 95 1017964895
   PubMed Web of Science ®Google Scholar
• SantosDEstevesARSilvaDFJanuárioCCardosoSMThe impact of mitochondrial fusion and fission modulation in sporadic Parkinson’s diseaseMol Neurobiol2015521 573 58625218511
   PubMed Web of Science ®Google Scholar
• SwerdlowRHParksJKMillerSWOrigin and functional consequences of the complex I defect in Parkinson’s diseaseAnn Neurol1996404 663 6718871587
   PubMed Web of Science ®Google Scholar
• TrimmerPABennettJPThe cybrid model of sporadic Parkinson’s diseaseExp Neurol20092182 320 32519328199
   PubMed Web of Science ®Google Scholar
• DauerWPrzedborskiSParkinson’s diseaseNeuron2003396 889 90912971891
   PubMed Web of Science ®Google Scholar
• Iglesias-gonzálezJSánchez-iglesiasSMéndez-ÁlvarezEDifferential toxicity of 6-hydroxydopamine in SH-SY5Y human neuroblastoma cells and rat brain mitochondria: protective role of catalase and superoxide dismutaseNeurochem Res20123710 2150 216022821477
   PubMed Web of Science ®Google Scholar
• WinklhoferKFHaassCMitochondrial dysfunction in Parkinson’s diseaseBiochim Biophys Acta201018021 29 4419733240
   PubMed Web of Science ®Google Scholar
• JanaSSinhaMChandaDMitochondrial dysfunction mediated by quinone oxidation products of dopamine: implications in dopamine cytotoxicity and pathogenesis of Parkinson’s diseaseBiochim Biophys Acta201118126 663 67321377526
   PubMed Web of Science ®Google Scholar
• BenderAKrishnanKJMorrisCMHigh levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson diseaseNat Genet2006385 515 51716604074
   PubMed Web of Science ®Google Scholar
• DeasEWoodNWPlun-favreauHMitophagy and Parkinson’s disease: the PINK1-parkin linkBiochim Biophys Acta201118134 623 63320736035
   PubMed Web of Science ®Google Scholar
• DingWXYinXMMitophagy: mechanisms, pathophysiological roles, and analysisBiol Chem20123937 547 56422944659
   PubMed Web of Science ®Google Scholar
• PickrellAMYouleRJThe roles of PINK1, parkin, and mitochondrial fidelity in Parkinson’s diseaseNeuron2015852 257 27325611507
   PubMed Web of Science ®Google Scholar
• NarendraDPJinSMTanakaAPINK1 is selectively stabilized on impaired mitochondria to activate parkinPLoS Biol201081 e100029820126261
   PubMed Web of Science ®Google Scholar
• Vives-BauzaCZhouCHuangYPINK1-dependent recruitment of Parkin to mitochondria in mitophagyProc Natl Acad Sci U S A20101071 378 38319966284
   PubMed Web of Science ®Google Scholar
• MatsudaNSatoSShibaKPINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagyJ Cell Biol20101892 211 22120404107
   PubMed Web of Science ®Google Scholar
• LeeSZhangCLiuXRole of glucose metabolism and ATP in maintaining PINK1 levels during Parkin-mediated mitochondrial damage responsesJ Biol Chem20152902 904 91725404737
   PubMed Web of Science ®Google Scholar
• Van LaarVSArnoldBCassadySJChuCTBurtonEABermanSBBioenergetics of neurons inhibit the translocation response of Parkin following rapid mitochondrial depolarizationHum Mol Genet2011205 927 94021147754
   PubMed Web of Science ®Google Scholar
• NorrisKLHaoRChenLFConvergence of Parkin, PINK1, and α-synuclein on stress-induced mitochondrial morphological remodelingJ Biol Chem201529022 13862 1387425861987
   PubMed Web of Science ®Google Scholar
• LiuWVives-BauzaCAcín-PerézRPINK1 defect causes mitochondrial dysfunction, proteasomal deficit and alpha-synuclein aggregation in cell culture models of Parkinson’s diseasePLoS One200942 e459719242547
   PubMed Web of Science ®Google Scholar
• DeviLAnandatheerthavaradaHKMitochondrial trafficking of APP and alpha synuclein: relevance to mitochondrial dysfunction in Alzheimer’s and Parkinson’s diseasesBiochim Biophys Acta201018021 11 1919619643
   PubMed Web of Science ®Google Scholar
• ChintaSJMallajosyulaJKRaneAAndersenJKMitochondrial α-synuclein accumulation impairs complex I function in dopaminergic neurons and results in increased mitophagy in vivoNeurosci Lett20104863 235 23920887775
   PubMed Web of Science ®Google Scholar
• DeviLRaghavendranVPrabhuBMAvadhaniNGAnandatheerthavaradaHKMitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brainJ Biol Chem200828314 9089 910018245082
   PubMed Web of Science ®Google Scholar
• ReeveAKLudtmannMHAngelovaPRAggregated α-synuclein and complex I deficiency: exploration of their relationship in differentiated neuronsCell Death Dis20156 e182026181201
   PubMed Web of Science ®Google Scholar
• BirASenOAnandSα-Synuclein-induced mitochondrial dysfunction in isolated preparation and intact cells: implications in the pathogenesis of Parkinson’s diseaseJ Neurochem20141316 868 87725319443
   PubMed Web of Science ®Google Scholar
• KampFExnerNLutzAKInhibition of mitochondrial fusion by α-synuclein is rescued by PINK1, Parkin and DJ-1EMBO J20102920 3571 358920842103
   PubMed Web of Science ®Google Scholar
• JennerPOlanowCWOxidative stress and the pathogenesis of Parkinson’s diseaseNeurology1996476 suppl 3 161S 170S
   PubMed Web of Science ®Google Scholar
• SoficERiedererPHeinsenHIncreased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brainJ Neural Transm1988743 199 2053210014
   PubMed Web of Science ®Google Scholar
• CassarinoDSFallCPSwerdlowRHElevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson’s diseaseBiochim Biophys Acta199713621 77 869434102
   PubMed Web of Science ®Google Scholar
• Di MaioRBarrettPJHoffmanEKα-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson’s diseaseSci Transl Med20168342 342ra78
   Web of Science ®Google Scholar
• AnandhanARodriguez-rochaHBohovychIOverexpression of alpha-synuclein at non-toxic levels increases dopaminergic cell death induced by copper exposure via modulation of protein degradation pathwaysNeurobiol Dis201581 76 9225497688
   PubMed Web of Science ®Google Scholar
• CarboniELingorPInsights on the interaction of alpha-synuclein and metals in the pathophysiology of Parkinson’s diseaseMetallomics201573 395 40425648629
   PubMed Web of Science ®Google Scholar
• HastingsTGThe role of dopamine oxidation in mitochondrial dysfunction: implications for Parkinson’s diseaseJ Bioenerg Biomembr2009416 469 47219967436
   PubMed Web of Science ®Google Scholar
• LeongSLCappaiRBarnhamKJPhamCLModulation of alpha-synuclein aggregation by dopamine: a reviewNeurochem Res20093410 1838 184619444607
   PubMed Web of Science ®Google Scholar
• CristóvãoACGuhathakurtaSBokENADPH oxidase 1 mediates α-synucleinopathy in Parkinson’s diseaseJ Neurosci20123242 14465 1447723077033
   PubMed Web of Science ®Google Scholar
• SchildknechtSGerdingHRKarremanCOxidative and nitrative alpha-synuclein modifications and proteostatic stress: implications for disease mechanisms and interventions in synucleinopathiesJ Neurochem20131254 491 51123452040
   PubMed Web of Science ®Google Scholar